NeOnc Technologies Holdings, Inc. Common Stock Market Cap ($72.88 Million)
Market Cap & Net Worth: NeOnc Technologies Holdings, Inc. Common Stock (NTHI)
NeOnc Technologies Holdings, Inc. Common Stock market cap. NeOnc Technologies Holdings, Inc. Common Stock (NASDAQ:NTHI) has a market capitalization of $72.88 Million ($72.88 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #20254 globally and #4629 in its home market, demonstrating a 8.87% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NeOnc Technologies Holdings, Inc. Common Stock's stock price $3.07 by its total outstanding shares 28805380 (28.81 Million). Also see NeOnc Technologies Holdings, Inc. Common cash conversion from operations for how efficiently the company converts equity into cash flow.
NeOnc Technologies Holdings, Inc. Common Stock Market Cap History (2025–2026)
NeOnc Technologies Holdings, Inc. Common Stock market cap history from 2025 to 2026. Data shows change from $238.22 Million to $88.43 Million (-30.87% CAGR). Check NTHI stock price and chart for real-time trading data and today's change.
NeOnc Technologies Holdings, Inc. Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NeOnc Technologies Holdings, Inc. Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore NTHI net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
5957.00x
NeOnc Technologies Holdings, Inc. Common Stock's market cap is 5957.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $238.22 Million | $39.99K | -$62.15 Million | 5957.00x | N/A |
Competitor Companies of NTHI by Market Capitalization
Companies near NeOnc Technologies Holdings, Inc. Common Stock in the global market cap rankings as of November 4, 2026. Also see NeOnc Technologies Holdings, Inc. Common balance sheet assets for a full breakdown of the balance sheet.
Key companies related to NeOnc Technologies Holdings, Inc. Common Stock by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #368 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #414 globally with a market cap of $68.22 Billion USD ( AU$96.41 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $530.76 |
| #368 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $973.36 |
| #414 | CSL Ltd | AU:CSL | $68.22 Billion | AU$198.72 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $228.44 |
Market Capitalization of NeOnc Technologies Holdings, Inc. Common Stock (2025–2026)
Market capitalization of NeOnc Technologies Holdings, Inc. Common Stock from 2025 to today. Between 2025 and today, NeOnc Technologies Holdings, Inc. Common Stock's market cap moved from $238.22 Million to $ 88.43 Million, with a yearly change of -30.87%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $88.43 Million | -62.88% |
| 2025 | $238.22 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of NeOnc Technologies Holdings, Inc. Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $72.88 Million USD |
| MoneyControl | $72.88 Million USD |
| MarketWatch | $72.88 Million USD |
| marketcap.company | $72.88 Million USD |
| Reuters | $72.88 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About NeOnc Technologies Holdings, Inc. Common Stock
NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical… Read more